Scilex Holding Company — Form 8-K Summary
Business context and reporting period
Scilex Holding Company filed a Form 8-K on April 5, 2024, reporting the results of its 2024 Annual Meeting of Stockholders held that day. The filing does not provide operating or financial results for a reporting period.
Financial and operating metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes versus the prior comparable period
No financial or operating comparison is presented. The principal reported event was the annual stockholder vote.
Meeting results, outlook, and risks
- 125,198,773 shares, representing 64.1% of the common stock and Series A preferred stock outstanding as of the record date, were represented virtually or by proxy.
- Proposal 1: Class II director nominees Jay Chun, M.D., Ph.D., and Yue Alexander Wu, Ph.D., were elected to serve until the 2027 Annual Meeting.
- Jay Chun received 113,207,991 votes for, 3,864,204 votes withheld, and 8,126,578 broker non-votes.
- Yue Alexander Wu received 111,155,502 votes for, 5,916,693 votes withheld, and 8,126,578 broker non-votes.
- Proposal 2: Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 122,076,431 votes for, 2,174,808 against, and 947,534 abstentions.
- The filing provides no management guidance, business outlook, contingencies, unusual items, or specific risk updates.
Important facts to verify
- Confirm the elected directors’ roles, committee assignments, and any subsequent governance changes.
- Review the definitive proxy statement filed March 12, 2024 for proposal details and voting procedures.
- Monitor subsequent filings for financial results, liquidity, debt obligations, auditor developments, and operational guidance.
- Note that the filing reports broker non-votes for the director election; these votes were not included as votes for or against the nominees.